Patent ductus arteriosus: emerging trial evidence firmly supports conservative management in preterm infants

Current Opinion in Pediatrics 2026

View at publisher
Authors: Nehal A. Parikh, Sanjana Velu
DOI: 10.1097/mop.0000000000001543
Cited by: 3
References: 28

Abstract

PURPOSE OF REVIEW: To summarize recent evidence from randomized clinical trials (RCT) and meta-analysis of patent ductus arteriosus (PDA) closure therapies versus conservative/expectant management on key outcomes such as bronchopulmonary dysplasia (BPD) or death in very preterm (

Fields of Study & Subjects

Cardiovascular Conditions and Treatments Congenital Heart Disease Studies Congenital Ear and Nasal Anomalies

Publication details

Journal / source
Current Opinion in Pediatrics
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
38
Issue
2
Pages
200–206
Publication date
19 January 2026
Language
EN